Prevalence and Determinants of Vaginal Infection With Human Papillomavirus Among Female University Students in Vietnam

Cervical cancer is the second most common malignancy among women in Vietnam, but the country is yet to introduce a national human papillomavirus (HPV) vaccine programme targeted at adolescents. We determined HPV prevalence and HPV vaccine knowledge among female university students in Vietnam. We sur...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:In vivo (Athens) 2022-01, Vol.36 (1), p.241-250
Hauptverfasser: VAN Trang, Nguyen, Prem, Kiesha, Toh, Zheng Quan, Viet Ha, Bui Thi, Ngoc Lan, Pham Thi, Tran, Hau Phuc, Pham, Quang Duy, VAN Khuu, Nghia, Jit, Mark, Luu, Dung Thi, Khanh Ly, LE Thi, Cao, VAN, LE-Ha, Tam-Duong, Bright, Kathryn, Garland, Suzanne M, Anh, Dang Duc, Mulholland, Kim
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Cervical cancer is the second most common malignancy among women in Vietnam, but the country is yet to introduce a national human papillomavirus (HPV) vaccine programme targeted at adolescents. We determined HPV prevalence and HPV vaccine knowledge among female university students in Vietnam. We surveyed and screened 1,491 female university students in Hanoi, Hue, and Ho Chi Minh City for their sexual behaviours, HPV knowledge and low- and high-risk HPV infection. The prevalence of any HPV infection and any high-risk HPV infection were 4.2% (95%CI=3.3%-5.4%) and 3.4% (95%CI=2.5%-4.4%), respectively. Being sexually active [adjusted prevalence ratio (aPR): 6.22; 95%CI=3.4-11.37] and having ever been pregnant (aPR: 4.82; 95%CI=1.93-12.04) were positively associated with high-risk HPV infection. Whilst 60% of participants had heard of HPV vaccine, only 4.6% had received the vaccine. The low HPV prevalence found in university students in Vietnam indicates that they can benefit from HPV vaccination, along with a well-designed HPV health promotion programme.
ISSN:0258-851X
1791-7549
DOI:10.21873/invivo.12697